95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.60%
Revenue growth at 50-75% of RGLD's 6.79%. Martin Whitman would worry about competitiveness or product relevance.
-0.21%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1.18%
EBIT growth below 50% of RGLD's 5.21%. Michael Burry would suspect deeper competitive or cost structure issues.
1.18%
Operating income growth under 50% of RGLD's 5.21%. Michael Burry would be concerned about deeper cost or sales issues.
7.19%
Net income growth above 1.5x RGLD's 4.07%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
7.89%
EPS growth above 1.5x RGLD's 2.44%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
7.89%
Diluted EPS growth above 1.5x RGLD's 5.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.06%
Share reduction more than 1.5x RGLD's 0.26%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.02%
Reduced diluted shares while RGLD is at 0.15%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
199.89%
Dividend growth above 1.5x RGLD's 0.05%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-2.13%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
453.95%
Positive FCF growth while RGLD is negative. John Neff would see a strong competitive edge in net cash generation.
571.98%
10Y revenue/share CAGR at 75-90% of RGLD's 670.80%. Bill Ackman would press for new markets or product lines to narrow the gap.
174.59%
5Y revenue/share CAGR 1.25-1.5x RGLD's 128.46%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
295.52%
3Y revenue/share CAGR above 1.5x RGLD's 188.98%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
9273.18%
10Y OCF/share CAGR above 1.5x RGLD's 376.81%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
242.80%
5Y OCF/share CAGR above 1.5x RGLD's 136.67%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
489.03%
3Y OCF/share CAGR under 50% of RGLD's 2801.62%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
13730.08%
Net income/share CAGR above 1.5x RGLD's 446.53% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
280.54%
5Y net income/share CAGR above 1.5x RGLD's 77.22%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
321.94%
Positive short-term CAGR while RGLD is negative. John Neff would see a clear advantage in near-term profit trajectory.
2138.64%
10Y equity/share CAGR at 75-90% of RGLD's 2596.65%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
158.46%
5Y equity/share CAGR at 50-75% of RGLD's 271.74%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
128.51%
3Y equity/share CAGR above 1.5x RGLD's 80.11%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-66.87%
Firm’s AR is declining while RGLD shows 18.63%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
4.04%
Asset growth at 75-90% of RGLD's 5.38%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
4.81%
BV/share growth above 1.5x RGLD's 0.52%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-8.33%
We’re deleveraging while RGLD stands at 50.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-7.24%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.